1. Market Research
  2. > Healthcare
  3. > Health Services Market Trends
Europe Autotransfusion Devices Market to 2027 - Regional Analysis and Forecasts by Type ; Application ; End User ; and Country

Europe Autotransfusion Devices Market to 2027 - Regional Analysis and Forecasts by Type ; Application ; End User ; and Country

  • March 2020
  • 140 pages
  • ID: 5887350
  • Format: PDF
  • The Insight Partners
Up to $1000 off Until Dec 10th 2020


Table of Contents

Search Inside

The autotransfusion devices market in Europe is estimated to reach US$ 360.92 million by 2027 from US$ 273.87 million in 2019; it is projected to grow at a CAGR of 3.6% during 2020–2027.
The growth of this market primarily attributed to the involvement of rare blood groups, rising number of transplant procedures, and growing prevalence of chronic diseases in Europe.Disadvantages of autotransfusion devices products, including risks associated with the autotransfusion process, and high costs of autotransfusion devices are limiting the growth of the market.

On the other hand, need for reinfusion of blood, and advancements in healthcare facilities and infrastructure are the factors that are expected to have a positive impact on the growth of the autotransfusion devices market in Europe during 2020–2027.
The process of autotransfusion involves the reinfusion of patient’s blood collected from the peritoneal cavity or thorax region.The process can be carried out before surgery or during and after the surgery using autotransfusion systems.

Medical procedures such as joint replacement, spinal surgeries, and cardiac surgeries require autotransfusion.These procedures are followed by excessive blood loss, and it is difficult to obtain blood of rare group in emergency cases.

Autotransfusion system facilitates to reinfuse the patient’s blood back into the body after the due filtration process.Moreover, it helps reduce the risk of infection, as well as eliminates the problems and complications associated with the banking and administration of homologous donor blood.

It helps prevent the transmission of transfusion-related blood-borne diseases in patients.
In Germany, AB positive is a rarely found blood group, and it was found in ~82.9 million (7.0%) of the population in 2019. Arranging blood in case of medical emergencies involving such people becomes difficult, and in such cases, medical professionals prefer to have an autotransfusion system equipped at their facilities where the patients’ blood is reinfused in their bodies. Thus, the medical cases involving rare blood group population are likely to continue to boost the market in the coming years.
In 2019, the accessories segment accounted for the largest share of the autotransfusion devices market in Europe.The prevalence of autologous blood transfusion in major orthopedic and cardiovascular surgeries would spur the demand for autotransfusion devices in this region.

Also, a greater preference for autotransfusion technique over allogeneic one due to higher chances of graft versus host disease-induced infection drives the overall market, thereby fueling the market for accessories.
In 2019, the hospitals segment held a significant share of the autotransfusion devices market in Europe.This segment is also anticipated to hold a considerable portion of the market by 2027 and is likely to register a high CAGR in the market during the forecast period.

The healthcare sector is a priority for the European Union (EU), and this has reflected in the European Regional Development Fund (ERDF – or EFRE in German) program 2014-2020 and the German Länder implementation and tendering of this program. “Horizon Europe,” a European Incentive Program for Research and Innovation agreed upon by the EU Council and Parliament, and scheduled to begin on January 1, 2021, also focuses on the healthcare sector as well as related R&D. Such developments are likely to contribute to the autotransfusion devices market in near future. The autotransfusion devices are majorly used during the surgical procedures in hospitals. Hospitals are primary healthcare centers for people, and among the admitted patients, most of them are already suffering from some disorders, related to blood transfusion. Thus, hospitals are contributing a significant market share to the autotransfusion devices market and are expected to continue the trend during the forecast period.

Several significant primary and secondary sources referred to for making this report on the autotransfusion devices market include the World Health Organization (WHO), Centers for Disease Control and Prevention (CDC), and European Journal of Cancer.

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 150+ Million searchable statistics with tables, figures & datasets
  • More than 25,000 trusted sources
20% Off


  • Single User License — provides access to the report by one individual.
  • Department License — allows you to share the report with up to 5 users
  • Site License — allows the report to be shared amongst all employees in a defined country
  • Corporate License — allows for complete access, globally.
Ahmad helps you find the right report:

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

We were impressed with the support that ReportLinker’s research specialists’ team provided. The report we purchased was useful and provided exactly what we want.

Category Manager at

ReportLinker gave access to reliable and useful data while avoiding dispersing resources and spending too much time on unnecessary research.

Executive Director at
PwC Advisory

The customer service was fast, responsive, and 100% professional in all my dealings (...) If we have more research needs, I'll certainly prioritize working with ReportLinker!

Scott Griffith

Vice President Marketing at
Maurice Sporting Goods

The research specialist provided prompt, helpful instructions for accessing ReportLinker's product. He also followed up to make sure everything went smoothly and to ensure an easy transition to the next stage of my research

Jessica P Huffman

Research Associate at
American Transportation Research Institute

Excellent customer service. Very responsive and fast.

Director, Corporate Strategy at

I reached out to ReportLinker for a detailed market study on the Air Treatment industry. The quality of the report, the research specialist’s willingness to solve my queries exceeded my expectations. I would definitely recommend ReportLinker for in-depth industry information.

Mariana Mendoza

Global Platform Senior Manager at
Whirlpool Corporation

Thanks! I like what you've provided and will certainly come back if I need to do further research works.

Bee Hin Png

CEO at
LDR Pte Ltd

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

  • How we can help
    • I am not sure if the report I am interested in will fulfill my needs. Can you help me?
    • Yes, of course. You can call us at +33(0) 4 37 65 17 03 or drop us an email at researchadvisor@reportlinker.com to let us know more about your requirements.
    • We buy reports often - can ReportLinker get me any benefits?
    • Yes. Set up a call with a Senior Research Advisor to learn more - researchadvisor@reportlinker.com or +33(0) 4 37 65 17 03.
    • I have had negative experiences with market research reports before. How can you avoid this from happening again?
    • We advise all clients to read the TOC and Summary and list your questions so that we can get more insight for you before you make any purchase decision. A research advisor will accompany you so that you can compare samples and reports from different sources, and choose the study that is right for you.

  • Report Delivery
    • How and when I will receive my Report?
    • Most reports are delivered right away in a pdf format, while others are accessed via a secure link and access codes. Do note that sometimes reports are sent within a 12 hour period, depending on the time zones. However, you can contact us to escalate this. Should you need a hard copy, you can check if this option is offered for the particular report, and pay the related fees.
  • Payment conditions
    • What payment methods do you accept?
      1. Credit card : VISA, American Express, Mastercard, or
      2. You can download an invoice to pay by wire transfer, check, or via a Purchase Order from your company, or
      3. You can pay via a Check made out in US Dollars, Euros, or British Pounds for the full amount made payable to ReportLinker
    • What are ReportLinker’s Payment Terms?
    • All payments must normally be submitted within 30 days. However, you can let us know if you need extended time.
    • Are Taxes and duties included?
    • All companies based in France must pay a 20% tax per report. The same applies to all individuals based in the EU. All EU companies must supply their VAT number when purchasing to avoid this charge.
    • I’m not satisfied. Can I be refunded?
    • No. Once your order has been processed and the publisher has received a notification to send you the report, we cannot issue any refund or cancel any order. As these are not ‘traditional’ products that can be returned, reports that are dispatched are considered to be ‘consumed’.
  • User license
    • The license that you should acquire depends on the number of persons that need to access the report. This can range from Single User (only one person will have the right to read or access the report), or Department License (up to 5 persons), to Site License (a group of persons based in the same company location), or Corporate License (the entire company personnel based worldwide). However, as publishers have different terms and conditions, we can look into this for you.
Purchase Reports From Reputable Market Research Publishers

Autotransfusion Device Market Forecast to 2027 - COVID-19 Impact and Global Analysis by Type ; Application ; End User ; and Geography

  • $ 4500
  • October 2020
  • 178 pages

The autotransfusion device market was valued at US$ 936.64 million in 2019 and is projected to reach US$ 1,270.67 million by 2027; it is expected to grow at a CAGR of 4.0% from 2020 to 2027. Factors such ...

  • World
  • North America
  • Healthcare
  • Specialty Hospital
  • Industry analysis
  • Health Expenditure
  • Chronic Disease Prevalence


Reportlinker.com © Copyright 2020. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.

Make sure you don’t miss any news and follow us on